Latest filing published 02 Jun 2026 for Caris Life Sciences, Inc., €22k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
George Poste (senior executive) discloses dealings in 3 companies, chiefly Exelixis, Inc., Caris Life Sciences, Inc. and Monsanto Co /NEW/. Between 4 January 2016 and 29 May 2026, the trades on record add up to 18 filings.
Every open-market trade on record is a sale: 4 sales worth €4.9M. Besides market trades, the filings include 9 share grants and 5 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
The record was last updated on 2 June 2026 with a share grant (€22k) in Caris Life Sciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations